Immunotherapy

Filter By:

immunotherapy illustration
Drug delivery technique makes cancer immunotherapy more effective

Researchers in the Institute for Molecular Engineering at the University of Chicago (IME) have developed a new way to target immunotherapies and deliver them directly to tumors.

Michael Bishop, MD, in cellular therapy laboratory
UChicago Medicine surges ahead with revolutionary CAR T-cell cancer treatment
CAR T-cell therapy patient Andrew Parker
CAR T-cell therapy recipient surpasses 3-year cancer-free mark
Jacelyn Walsh, CAR T-cell therapy patient
After years of treatment and three relapses, CAR T-cell therapy offers hope for leukemia patient
Three years after CAR T-cell therapy for lymphoma, patient still cancer-free
Scott McIntyre, CAR T-cell therapy recipient
Sonali Smith, MD, Michael Bishop, MD, and Tim Brown: At the Forefront Live Immunotherapy
At the Forefront Live: Immunotherapy and Using the Body to Fight Cancer
two staff members in Advanced Cellular Therapeutics Facility (ACTF)
New facility brings the most advanced cellular therapies to patients
Chuan He
Power of cancer immunotherapy expanded by improved antigen presentation
CAR-T therapy patient Scott McIntyre with Michael Bishop, MD
CAR T-cell update: therapy improves outcomes for patients with B-cell lymphoma
The Checkpoints
A band of scientists
T-cells
New checkpoint inhibitor shows promise in clinical trial for non-Hodgkin’s lymphoma
Novel biomarker found in ovarian cancer patients can predict response to therapy
Ovarian cancer cells (Image: National Cancer Institute)
Akash Patnaik looking at a slide
An unexpected success for cancer immunotherapy treating prostate cancer
Patient Elaine Johnson (center) with Grace Suh and Michael Bishop
Dreams do come true after advanced care for lymphoma
AACR 2018 group, including Funmi Olopade, MD, and Ivy Elkins, lung cancer survivor
2018 AACR annual meeting: Driving innovative cancer science to patient care
Load More article cards